Sai Life Sciences Ltd (SAILIFE) is currently trading at 849.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Sai Life Sciences Limited is an integrated CRDMO offering end-to-end services across drug discovery, development, and manufacturing. The company serves global pharmaceutical innovators, providing integrated solutions. In the latest financial quarter, Sai Life Sciences achieved a 36% revenue growth year-on-year with a revenue of ₹537 crore, reflecting strong performance in both their CRO and CDMO services. The company is executing a substantial capacity expansion plan from 700 KL to 1150 KL by FY27, supported by a planned capex of ₹700 crore in FY26, enhancing R&D and manufacturing capabilities. Strategic collaborations with UK-based firms are allowing Sai to extend its CMC offerings globally, demonstrating an international growth strategy and broadening its service portfolio. Sai Life Sciences is leading in adopting new technologies and modalities like peptides, ADCs, and oligonucleotides to stay ahead in the competitive CRDMO market, enhancing their innovation pipeline and capability spectrum.

Over the past 52 weeks, Sai Life Sciences Ltd has traded between a low of ₹635.30 and a high of ₹983.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Sai Life Sciences Ltd has a market capitalization of approximately 17,933.53. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Sai Life Sciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 52.86 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Sai Life Sciences Ltd (SAILIFE) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 17,933.53 Cr, Sai Life Sciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Sai Life Sciences Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Sai Life Sciences Ltd is 52.86. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Sai Life Sciences Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.

Key risks associated with Sai Life Sciences Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.